Graves‘ disease in children and adolescents in Iceland
INTRODUCTION: Graves‘ disease is an autoimmune disease in which autoantibodies cause an increase in the production of thyroid hormones, and is the most common cause of thyrotoxicosis in children. Symptoms in children are often more obscure than in adults. The aim of the study is to assess the incide...
Gespeichert in:
| Veröffentlicht in: | Laeknabladid Jg. 108; H. 3; S. 123 - 129 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Journal Article |
| Sprache: | Englisch Isländisch |
| Veröffentlicht: |
Iceland
01.03.2022
|
| Schlagworte: | |
| ISSN: | 0023-7213, 1670-4959, 1670-4959 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | INTRODUCTION: Graves‘ disease is an autoimmune disease in which autoantibodies cause an increase in the production of thyroid hormones, and is the most common cause of thyrotoxicosis in children. Symptoms in children are often more obscure than in adults. The aim of the study is to assess the incidence of Graves’ disease in children and adolescents in Iceland over the span of two decades (2001-2021), and furthermore to investigate if the incidence rate has increased, as well as to describe treatment options and disease recurrence. MATERIAL/METHODS: This retrospective descriptive study included all children diagnosed with Graves‘ disease in the years 2001-2021 in Iceland. Information was obtained from the Directorate of Health‘s drug database and from ICD-10 diagnoses at Landspítali – The National University Hospital. RESULTS: In total, 57 children and adolescents were diagnosed with Graves’, the overall incidence rate was 3.5/100,000 person-years. Gender ratio was 1:2.7 (male : female) and the mean age at diagnosis was 13.6 for boys and 13.9 years for girls. Of those 12 individuals currently receiving drug therapy (21.8%), four patients have had disease relapse. Thirteen patients reached an euthyroid state with medication (23.7%), 25 received treatment with radioactive iodine (45.5%) and 5 underwent surgery (9.1%). Boys were more likely to relapse. Disease recurrence was 31.8%. CONCLUSION: The incidence of Graves‘ disease did not increase during the study period. The disease was more common in girls, although the gender ratio was lower than expected. Antithyroid drugs were the first choice in treatment and radioactive iodine was the most common permanent treatment option. Disease recurrence was common. A possible relationship between the duration of the original drug therapy and disease recurrence should be investigated. |
|---|---|
| AbstractList | Graves' disease is an autoimmune disease in which autoantibodies cause an increase in the production of thyroid hormones, and is the most common cause of thyrotoxicosis in children. Symptoms in children are often more obscure than in adults. The aim of the study is to assess the incidence of Graves' disease in children and adolescents in Iceland over the span of two decades (2001-2021), and furthermore to investigate if the incidence rate has increased, as well as to describe treatment options and disease recurrence.
This retrospective descriptive study included all children diagnosed with Graves' disease in the years 2001-2021 in Iceland. Information was obtained from the Directorate of Health's drug database and from ICD-10 diagnoses at Landspítali - The National University Hospital.
In total, 57 children and adolescents were diagnosed with Graves', the overall incidence rate was 3.5/100,000 person-years. Gender ratio was 1:2.7 (male : female) and the mean age at diagnosis was 13.6 for boys and 13.9 years for girls. Of those 12 individuals currently receiving drug therapy (21.8%), four patients have had disease relapse. Thirteen patients reached an euthyroid state with medication (23.7%), 25 received treatment with radioactive iodine (45.5%) and 5 underwent surgery (9.1%). Boys were more likely to relapse. Disease recurrence was 31.8%.
The incidence of Graves' disease did not increase during the study period. The disease was more common in girls, although the gender ratio was lower than expected. Antithyroid drugs were the first choice in treatment and radioactive iodine was the most common permanent treatment option. Disease recurrence was common. A possible relationship between the duration of the original drug therapy and disease recurrence should be investigated. Graves' disease is an autoimmune disease in which autoantibodies cause an increase in the production of thyroid hormones, and is the most common cause of thyrotoxicosis in children. Symptoms in children are often more obscure than in adults. The aim of the study is to assess the incidence of Graves' disease in children and adolescents in Iceland over the span of two decades (2001-2021), and furthermore to investigate if the incidence rate has increased, as well as to describe treatment options and disease recurrence.INTRODUCTIONGraves' disease is an autoimmune disease in which autoantibodies cause an increase in the production of thyroid hormones, and is the most common cause of thyrotoxicosis in children. Symptoms in children are often more obscure than in adults. The aim of the study is to assess the incidence of Graves' disease in children and adolescents in Iceland over the span of two decades (2001-2021), and furthermore to investigate if the incidence rate has increased, as well as to describe treatment options and disease recurrence.This retrospective descriptive study included all children diagnosed with Graves' disease in the years 2001-2021 in Iceland. Information was obtained from the Directorate of Health's drug database and from ICD-10 diagnoses at Landspítali - The National University Hospital.MATERIAL/METHODSThis retrospective descriptive study included all children diagnosed with Graves' disease in the years 2001-2021 in Iceland. Information was obtained from the Directorate of Health's drug database and from ICD-10 diagnoses at Landspítali - The National University Hospital.In total, 57 children and adolescents were diagnosed with Graves', the overall incidence rate was 3.5/100,000 person-years. Gender ratio was 1:2.7 (male : female) and the mean age at diagnosis was 13.6 for boys and 13.9 years for girls. Of those 12 individuals currently receiving drug therapy (21.8%), four patients have had disease relapse. Thirteen patients reached an euthyroid state with medication (23.7%), 25 received treatment with radioactive iodine (45.5%) and 5 underwent surgery (9.1%). Boys were more likely to relapse. Disease recurrence was 31.8%.RESULTSIn total, 57 children and adolescents were diagnosed with Graves', the overall incidence rate was 3.5/100,000 person-years. Gender ratio was 1:2.7 (male : female) and the mean age at diagnosis was 13.6 for boys and 13.9 years for girls. Of those 12 individuals currently receiving drug therapy (21.8%), four patients have had disease relapse. Thirteen patients reached an euthyroid state with medication (23.7%), 25 received treatment with radioactive iodine (45.5%) and 5 underwent surgery (9.1%). Boys were more likely to relapse. Disease recurrence was 31.8%.The incidence of Graves' disease did not increase during the study period. The disease was more common in girls, although the gender ratio was lower than expected. Antithyroid drugs were the first choice in treatment and radioactive iodine was the most common permanent treatment option. Disease recurrence was common. A possible relationship between the duration of the original drug therapy and disease recurrence should be investigated.CONCLUSIONThe incidence of Graves' disease did not increase during the study period. The disease was more common in girls, although the gender ratio was lower than expected. Antithyroid drugs were the first choice in treatment and radioactive iodine was the most common permanent treatment option. Disease recurrence was common. A possible relationship between the duration of the original drug therapy and disease recurrence should be investigated. INTRODUCTION: Graves‘ disease is an autoimmune disease in which autoantibodies cause an increase in the production of thyroid hormones, and is the most common cause of thyrotoxicosis in children. Symptoms in children are often more obscure than in adults. The aim of the study is to assess the incidence of Graves’ disease in children and adolescents in Iceland over the span of two decades (2001-2021), and furthermore to investigate if the incidence rate has increased, as well as to describe treatment options and disease recurrence. MATERIAL/METHODS: This retrospective descriptive study included all children diagnosed with Graves‘ disease in the years 2001-2021 in Iceland. Information was obtained from the Directorate of Health‘s drug database and from ICD-10 diagnoses at Landspítali – The National University Hospital. RESULTS: In total, 57 children and adolescents were diagnosed with Graves’, the overall incidence rate was 3.5/100,000 person-years. Gender ratio was 1:2.7 (male : female) and the mean age at diagnosis was 13.6 for boys and 13.9 years for girls. Of those 12 individuals currently receiving drug therapy (21.8%), four patients have had disease relapse. Thirteen patients reached an euthyroid state with medication (23.7%), 25 received treatment with radioactive iodine (45.5%) and 5 underwent surgery (9.1%). Boys were more likely to relapse. Disease recurrence was 31.8%. CONCLUSION: The incidence of Graves‘ disease did not increase during the study period. The disease was more common in girls, although the gender ratio was lower than expected. Antithyroid drugs were the first choice in treatment and radioactive iodine was the most common permanent treatment option. Disease recurrence was common. A possible relationship between the duration of the original drug therapy and disease recurrence should be investigated. |
| Author | Jónasdóttir, Soffía Guðrún Bjarnason, Ragnar Þórsson, Þórbergur Atli Jónsdóttir, Berglind |
| Author_xml | – sequence: 1 givenname: Þórbergur Atli surname: Þórsson fullname: Þórsson, Þórbergur Atli – sequence: 2 givenname: Ragnar surname: Bjarnason fullname: Bjarnason, Ragnar – sequence: 3 givenname: Soffía Guðrún surname: Jónasdóttir fullname: Jónasdóttir, Soffía Guðrún – sequence: 4 givenname: Berglind surname: Jónsdóttir fullname: Jónsdóttir, Berglind |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35230257$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kL9OwzAQhy1UREvpzoQysiSc7cR_RlRBqVSJBWbLds4iKE1K3CKx8Rg8H0-CSwu3nHT36fS775yMur5DQi4pFFRqzW5a1xYMGCuAF0LBCZlQISEvdaVHZALAeC4Z5WMyi_EVUgmgWsszMuYV48AqOSFqMdh3jN-fX1ndRLQRs6bL_EvT1gN2me3qzNZ9i9Fjt4373dJjm8YX5DTYNuLs2Kfk-f7uaf6Qrx4Xy_ntKveMlducUgghALNclwqV1E45SdGLyjpwVtMgFJMlgBRaBWXBcR4st56BU1R7PiXXh7uboX_bYdyadZPCtCkD9rtomOClqqAsZUKvjujOrbE2m6FZ2-HD_H2bADgAfuhjHDD8IxTMr1OTnJq9UwPcJKf8Bw88aDA |
| ContentType | Journal Article |
| CorporateAuthor | Faculty of Medicine, Department of Health Sciences, University of Iceland, Reykjavík Faculty of Medicine, Department of Health Sciences, University of Iceland, Reykjavík, Childrens Hospital Hringurinn, National University Hospital of Iceland, Reykjavík Childrens Hospital Hringurinn, National University Hospital of Iceland, Reykjavík Domus Medica, Reykjavík |
| CorporateAuthor_xml | – name: Domus Medica, Reykjavík – name: Faculty of Medicine, Department of Health Sciences, University of Iceland, Reykjavík, Childrens Hospital Hringurinn, National University Hospital of Iceland, Reykjavík – name: Childrens Hospital Hringurinn, National University Hospital of Iceland, Reykjavík – name: Faculty of Medicine, Department of Health Sciences, University of Iceland, Reykjavík |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.17992/lbl.2022.03.680 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1670-4959 |
| EndPage | 129 |
| ExternalDocumentID | 35230257 10_17992_lbl_2022_03_680 |
| Genre | Journal Article |
| GeographicLocations | Iceland |
| GeographicLocations_xml | – name: Iceland |
| GroupedDBID | 5GY 5VS AAYXX AENEX ALMA_UNASSIGNED_HOLDINGS CITATION DIK F5P GROUPED_DOAJ OK1 CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c224t-110fff02a3948e879b8b71ec65ab0ba91f68274007698f8a0b33fa3ac20b819c3 |
| ISICitedReferencesCount | 2 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000767003100003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0023-7213 1670-4959 |
| IngestDate | Thu Jul 10 19:56:40 EDT 2025 Thu Jan 02 22:53:23 EST 2025 Sat Nov 29 05:55:02 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Graves‘ disease treatment Iceland pediatric |
| Language | English Icelandic |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c224t-110fff02a3948e879b8b71ec65ab0ba91f68274007698f8a0b33fa3ac20b819c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.laeknabladid.is/media/2022-03/f01.pdf |
| PMID | 35230257 |
| PQID | 2634850447 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_2634850447 pubmed_primary_35230257 crossref_primary_10_17992_lbl_2022_03_680 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-Mar |
| PublicationDateYYYYMMDD | 2022-03-01 |
| PublicationDate_xml | – month: 03 year: 2022 text: 2022-Mar |
| PublicationDecade | 2020 |
| PublicationPlace | Iceland |
| PublicationPlace_xml | – name: Iceland |
| PublicationTitle | Laeknabladid |
| PublicationTitleAlternate | Laeknabladid |
| PublicationYear | 2022 |
| SSID | ssj0000601997 |
| Score | 2.21137 |
| Snippet | INTRODUCTION: Graves‘ disease is an autoimmune disease in which autoantibodies cause an increase in the production of thyroid hormones, and is the most common... Graves' disease is an autoimmune disease in which autoantibodies cause an increase in the production of thyroid hormones, and is the most common cause of... |
| SourceID | proquest pubmed crossref |
| SourceType | Aggregation Database Index Database |
| StartPage | 123 |
| SubjectTerms | Adolescent Child Female Graves Disease - diagnosis Graves Disease - epidemiology Graves Disease - therapy Humans Iceland - epidemiology Iodine Radioisotopes - adverse effects Male Neoplasm Recurrence, Local - chemically induced Neoplasm Recurrence, Local - drug therapy Retrospective Studies Thyroid Neoplasms |
| Title | Graves‘ disease in children and adolescents in Iceland |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/35230257 https://www.proquest.com/docview/2634850447 |
| Volume | 108 |
| WOSCitedRecordID | wos000767003100003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1670-4959 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000601997 issn: 0023-7213 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Pb9MwFLe6gRAXxH_KxhQkLghFOLET2wcOLYx_0qodhtRb5Dg2KlTp1KbTjnwMPtU-xD4J78VJlhZNYgcuVmTLr67fk_17fv8IecUtFrGIojAWxoRcJyrMtdEhYHteFLlgNtV1sQkxmcjpVB0PBhdtLMzZXJSlPD9Xp_-V1dAHzMbQ2RuwuyMKHfANTIcW2A7tPzH-ExYUWrVODLI1weDDRhe5XWdovcrlhGNfjG2qefTio-1PDK3SRev2vn6HhnV1iO2YLVdNuNZGJzqMrZdvRtV81un6PzSsuw3l199L3bkEf_WzYLTwX1U186XAFs7VVvwPGuS4HqO1WX88Krcnb88dwxIAPhf9Jw3Qhjufri7EgIWgmvqTz_qTORU0BG1ObRzdVPZklPUO4ihmvTs98q8qf10XQinMPzvP0QgVx5juNvWFpTYzc2_dmJ0fI2pQSCMDChlSyCjLgMIOuRWLRKmeiu-RAUW_Hu915P9hYzlHIm-3lrGJlK5Rf2oYdHKf3Gv0l2Dk5e4BGdjyIblz1HhoPCLSi9_lr99BI3jBrAxawQtAwoKe4OFYI3iPybePhyfvP4dNdY7QAOyrQsCNzjkaa6a4tFKoXOYisiZNdE5zrSKXylhwNPUq6aSmOWNOM0wJmgMMNewJ2S0XpX1GAmUMmnO5oehvyVOAsACaijQpIi2jxA3J63YnslOfhCW7buuH5GW7VRmclGj-0qVdrFdZnDIuE8q5GJKnfg87agyNI3B7Pb_BL-2Ru1fCu092q-XaviC3zVk1Wy0PyI6YyoOa_9BOjo_-AGdJiDw |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Graves%E2%80%98+disease+in+children+and+adolescents+in+Iceland&rft.jtitle=Laeknabladid&rft.au=%C3%9E%C3%B3rsson%2C+%C3%9E%C3%B3rbergur+Atli&rft.au=Bjarnason%2C+Ragnar&rft.au=J%C3%B3nasd%C3%B3ttir%2C+Soff%C3%ADa+Gu%C3%B0r%C3%BAn&rft.au=J%C3%B3nsd%C3%B3ttir%2C+Berglind&rft.date=2022-03-01&rft.issn=0023-7213&rft.eissn=1670-4959&rft.volume=108&rft.issue=3&rft.spage=123&rft.epage=129&rft_id=info:doi/10.17992%2Flbl.2022.03.680&rft.externalDBID=n%2Fa&rft.externalDocID=10_17992_lbl_2022_03_680 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0023-7213&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0023-7213&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0023-7213&client=summon |